SMT3 Suppressor of Mif Two 3 Homolog 1 (S. Cerevisiae) (SUMO1) antibody

Details for Product No. ABIN271649
Request Want additional data for this product?

The Independent Validation Initiative strives to provide you with high quality data. Find out more

(218), (70), (64), (2), (1), (1), (1), (1), (1)
(177), (41), (2), (2), (1)
(13), (13), (13), (8), (8), (8), (3), (3), (3), (3), (3), (3), (3), (3)
Western Blotting (WB), Immunohistochemistry (IHC), Immunohistochemistry (Paraffin-embedded Sections) (IHC (p))
(183), (90), (87), (64), (44), (31), (29), (24), (16), (16), (10), (7), (4), (2), (1)
Pubmed 5 references available
Quantity 0.1 mL
Shipping to United States (Change)
Availability Discontinued
Request Want additional data for this product?

The Independent Validation Initiative strives to provide you with high quality data. Find out more

Catalog No. ABIN271649
459.80 $
Plus shipping costs $45.00
Add to Basket

Order hotline:

  • +1 404 474 4654
  • +1 888 205 9894 (TF)
Immunogen A synthetic peptide (AKPST EDLGDKKEGE Y) as part of human SUMO-1 peptide (aa: 6-21) conjugated to diphtheria toxoid.
Specificity This antiserum recognises human SUMO-1 and not ubiquitin.
Purification Whole antisera
Alternative Name SUMO1
Background FUNCTION: Ubiquitin-like protein which binds to a wide range of target proteins. Doesnot seem to be involved in protein degradation and may function as an antagonist ofubiquitin in the degradation process. Plays a role in a number of cellular processes suchas nuclear transport, DNA replication and repair, mitosis and signal transduction.Involved in targeting RANGAP1 to the nuclear pore complex protein RANBP2.SUBUNIT: Covalently attached to a number of proteins such as PML, RANGAP1,HIPK2, SP100, p53, p73alpha, MDM2, JUN and DNMT3B. Also interacts with HIF1A,HIPK2, HIPK3, CHD3, PIAS1, EXOSC9, TDG, RAD51 and RAD52. SUBCELLULARLOCATION: Nucleus, nuclear membrane. Nucleus, nucleoplasm, nuclear speckle.Cytoplasm. SIMILARITY: Belongs to the ubiquitin family. SMT3 subfamily. SIMILARITY:Contains 1 ubiquitin-like domain. Alternate Names: anti-Small ubiquitin-related modifier 1 antibody, anti-Ubiquitin-like protein SMT3Cantibody, anti-SMT3 homolog 3 antibody, anti-Ubiquitin-homology domain protein PIC1antibody, anti-Ubiquitin-like protein UBL1 antibody, anti-GAP-modifying protein 1antibody, anti-GMP1 antibody, anti-Sentrin. GENE NAME: SUMO1 antibody,anti-SMT3C antibody, anti-SMT3H3 antibody, anti-UBL1 antibody, biosensis. Related Diseases: Alzheimer's/ Parkinson's
Gene Symbol: SUMO1
Gene ID 7341
Research Area Signaling, Proteases, DNA/RNA
Application Notes Cell lysate from Hela and NIH-3T3 cell lysates may be used as a positive control, and for IHC, lung carcinoma may be used.
Recommended dilutions: Immunohistochemistry 1:2000-1:4000, Immunohistochemistry-Paraffin 1:2000-1:4000, Western Blot 1:1000-1:2000
Restrictions For Research Use only
Format Lyophilized
Reconstitution Reconstitute in 100 µL of sterile water.
Buffer Lyophilized whole serum.
Preservative Without preservative
Handling Advice Avoid freeze-thaw cycles
Storage 4 °C
Storage Comment 4 °C short term. Aliquot and store at -20 °C long term.
General Yang, Sharrocks: "SUMO promotes HDAC-mediated transcriptional repression." in: Molecular cell, Vol. 13, Issue 4, pp. 611-7, 2004 (PubMed).

Ling, Sankpal, Robertson et al.: "Modification of de novo DNA methyltransferase 3a (Dnmt3a) by SUMO-1 modulates its interaction with histone deacetylases (HDACs) and its capacity to repress transcription." in: Nucleic acids research, Vol. 32, Issue 2, pp. 598-610, 2004 (PubMed).

Pountney, Huang, Burns et al.: "SUMO-1 marks the nuclear inclusions in familial neuronal intranuclear inclusion disease." in: Experimental neurology, Vol. 184, Issue 1, pp. 436-46, 2003 (PubMed).

Bailey, OHare: "Characterization of the localization and proteolytic activity of the SUMO-specific protease, SENP1." in: The Journal of biological chemistry, Vol. 279, Issue 1, pp. 692-703, 2003 (PubMed).

Ohshima, Shimotohno: "Transforming growth factor-beta-mediated signaling via the p38 MAP kinase pathway activates Smad-dependent transcription through SUMO-1 modification of Smad4." in: The Journal of biological chemistry, Vol. 278, Issue 51, pp. 50833-42, 2003 (PubMed).

Validation Images
Did you look for something else?
back to top